Ngā hua rapu kaituhi :: APM

1

The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review mā Ludivine Boudieu, M. Mennetrier, Pierre‐Michel Llorca, Ludovic Samalin

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

What’s New in Addiction Prevention in Young People: A Literature Review of the Last Years of Research mā Cédric Kempf, Pierre-Michel Llorca, Frank Pizon, Georges Brousse, Valentin Flaudias

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness mā Pierre‐Michel Llorca, Mocrane Abbar, Philippe Courtet, Sébastien Guillaume, Sylvie Lancrenon, Ludovic Samalin

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Stigmatization toward People with Anorexia Nervosa, Bulimia Nervosa, and Binge Eating Disorder: A Scoping Review mā Lisa Brelet, Valentin Flaudias, Michel Désert, Sébastien Guillaume, Pierre‐Michel Llorca, Yves Boirie‌

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia mā John M. Kane, Joseph P. McEvoy, Christoph U. Correll, Pierre‐Michel Llorca

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: A double-blind placebo-controlled trial mā Jonathan Davidson, Hans‐Ulrich Wïttchen, Pierre‐Michel Llorca, J. Erickson, Michael J. Detke, Susan Ball, James M. Russell

I whakaputaina 2008

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Investigational drugs in recent clinical trials for treatment-resistant depression mā Ricardo P. Garay, Carlos A. Zarate, Thomas Charpeaud, Leslie Citrome, Christoph U. Correll, Ahcène Hameg, Pierre‐Michel Llorca

I whakaputaina 2017

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis mā Damien Etchecopar‐Etchart, Théo Korchia, Anderson Loundou, Pierre‐Michel Llorca, Pascal Auquier, Christophe Lançon, Laurent Boyer, Guillaume Fond

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
9

A National Network of Schizophrenia Expert Centres: an Innovative Tool to Bridge the Research-Practice Gap mā Franck Schürhoff, Guillaume Fond, Fabrice Berna, E. Bulzacka, J. Vilain, Delphine Capdevielle, D. Misdrahi, Marion Leboyer, Pierre‐Michel Llorca

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

End-of-life care among patients with schizophrenia and cancer: a population-based cohort study from the French national hospital database mā Guillaume Fond, Sébastien Salas, Vanessa Pauly, Karine Baumstarck, Cécile Bernard, Véronica Orleans, Pierre‐Michel Llorca, Christophe Lançon, Pascal Auquier, Laurent Boyer

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study mā Guillaume Fond, Vanessa Pauly, Marc Léone, Pierre‐Michel Llorca, Véronica Orleans, Anderson Loundou, Christophe Lançon, Pascal Auquier, Karine Baumstarck, Laurent Boyer

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Real-world effectiveness of long-acting injectable antipsychotic treatments in a nationwide cohort of 12,373 patients with schizophrenia-spectrum disorders mā Laurent Boyer, Bruno Falissard, Philippe Nuss, C. Collin, Stephanie Duret, Marc Rabbani, Isabelle De Chefdebien, Isabelle Tonelli, Pierre‐Michel Llorca, Guillaume Fond

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Patient and physician perspectives of a smartphone application for depression: a qualitative study mā Marie-Camille Patoz, Diego Hidalgo‐Mazzei, Olivier Blanc, Norma Verdolini, Isabella Pacchiarotti, Andréa Murru, Laurent Zukerwar, Eduard Vieta, Pierre‐Michel Llorca, Ludovic Samalin

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Repetitive Transcranial Magnetic Stimulation (rTMS) as a Promising Treatment for Craving in Stimulant Drugs and Behavioral Addiction: A Meta-Analysis mā Aurélia Gay, Julien Cabé, I. de Chazeron, Céline Lambert, Maxime Defour, Vikesh Bhoowabul, Thomas Charpeaud, Aurore Tremey, Pierre‐Michel Llorca, Bruno Pereira, Georges Brousse

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
15

Contact dependent reproducible hypomania induced by deep brain stimulation in Parkinson's disease: clinical, anatomical and functional imaging study mā Miguel Ulla, Stéphane Thobois, Pierre‐Michel Llorca, Philippe Derost, Jean‐Jacques Lemaire, Isabelle Chéreau‐Boudet, I. de Chazeron, A. Schmitt, Bénédicte Ballanger, E. Broussolle, Franck Durif

I whakaputaina 2010

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Microbiota-Orientated Treatments for Major Depression and Schizophrenia mā Guillaume B. Fond, Jean‐Christophe Lagier, Stéphane Honoré, Christophe Lançon, Théo Korchia, Pierre-Louis Sunhary de Verville, Pierre‐Michel Llorca, Pascal Auquier, Éric Guedj, Laurent Boyer

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
17

Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial mā Mocrane Abbar, Christophe Dematteï, Wissam El‐Hage, Pierre‐Michel Llorca, Ludovic Samalin, Pierre Demaricourt, Raphaël Gaillard, Philippe Courtet, Guillaume Vaïva, Philip Gorwood, Pascale Fabbro‐Peray, Fabrice Jollant

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

F110. SYMPTOMATIC REMISSION WITH PALIPERIDONE PALMITATE 3-MONTHLY FORMULATION IN SCHIZOPHRENIA PATIENTS IN A CLINICAL PRACTICE SETTING mā María Paz García‐Portilla, Pierre‐Michel Llorca, Giuseppe Maina, Vasilis P. Bozikas, Halise Devrimci-Özgüven, Suck Won Kim, Paul Bergmans, I. Usankova, P. Chérubin, Dean Najarian, Katalin Pungor

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries mā Guillaume Fond, Katlyn Nemani, Damien Etchecopar‐Etchart, Anderson Loundou, Donald Goff, Seung Won Lee, Christophe Lançon, Pascal Auquier, Karine Baumstarck, Pierre‐Michel Llorca, Dong Keon Yon, Laurent Boyer

I whakaputaina 2021

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
20

Assurer les soins aux patients souffrant de troubles psychiques en France pendant l’épidémie à SARS-CoV-2 mā Astrid Chevance, D. Gourion, Nicolas Hoertel, Pierre‐Michel Llorca, Pierre Thomas, R. Bocher, Marie Rose Moro, Vincent Laprévote, Amine Benyamina, Philippe Fossati, Mala Masson, Édouard Leaune, Marion Leboyer, Raphaël Gaillard

I whakaputaina 2020

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i: